|
TRT affiliate has patented this indication in the USA and will soon initiate studies. CEApproval:https://www.storzmedical.com/en/news-press/entry/neurolith-ce-approval-transcranial-pulse-stimulation-tps-treatment-alzheimer-disease.html STORZ MEDICAL’s NEUROLITH® receives CE approval – Transcranial Pulse Stimulation (TPS) on the central nervous system of patients with Alzheimer’s disease - Lithotripsy Database / Blog In December 2018, STORZ MEDICAL has received the CE approval for the NEUROLITH ®, a new therapy system for the treatment of neurological diseases.. The technology behind the NEUROLITH ® is called Transcranial Pulse Stimulation (TPS). TPS consists of short acoustic pulses with an ultrasound frequency range that permits a well-focused stimulation of the brain at a depth of up to 5 cm.
The study is taking place at the prestigious clinic San Diego Sexual Medicine, with former SMSNA and ISSWSH president Dr Irwin Goldstein as principal investigator. The protocol was written by Sue Goldstein who manages clinical research at SDSM. Enrollment with commence immediately. Other top research centers interested in conducting in a similar study may contact TRT. |
Specializing in sales of medical devices using our patented acoustic wave technology to profoundly accelerate healing and recoveries for the human body.
|
|
TRT's OrthoGold 100 is FDA cleared for the activation of connective tissue, and FDA Registered for pain reduction
and improved blood supply.
and improved blood supply.
© Copyright Tissue Regeneration Technologies - 2018 | All Rights Reserved